상세 보기
Mechanisms of Acquired Resistance to First-Line Amivantamab Plus Lazertinib Vs Osimertinib: Updated Analysis from MARIPOSA
- Hayashi, H.;
- Besse, B.;
- Lee, S-H.;
- Lu, S.;
- Nguyen, D.;
- 외 15명
Citations
WEB OF SCIENCE
0키워드
Non-small cell lung cancer; EGFR mutation; amivantamab
- 제목
- Mechanisms of Acquired Resistance to First-Line Amivantamab Plus Lazertinib Vs Osimertinib: Updated Analysis from MARIPOSA
- 저자
- Hayashi, H.; Besse, B.; Lee, S-H.; Lu, S.; Nguyen, D.; Popat, S.; Yang, J. C. -H.; Gottfried, M.; Dias, J. Mourao; Martin, C.; Sendur, M. A. N.; Paz-Ares, L.; Owen, S.; Campelo, M. D. R. Garcia; Wang, B.; Sethi, S.; Shah, S.; Zhang, J.; Curtin, J. C.; Cho, B. C.
- 발행일
- 2025-10
- 유형
- Meeting Abstract
- 권
- 20
- 호
- 10